Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumors
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference15 articles.
1. Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity;Adusumilli;Sci. Transl. Med.,2014
2. A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab;Adusumilli;Cancer Discov.,2021
3. Regression of glioblastoma after chimeric antigen receptor T-cell therapy;Brown;N. Engl. J. Med.,2016
4. Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition;Cherkassky;J. Clin. Invest.,2016
5. CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma;Choi;J. Immunother. Cancer,2019
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies;Recent Patents on Anti-Cancer Drug Discovery;2024-12
2. Endovascular surgical neuro-oncology: advancing a new subspecialty;Journal of Neuro-Oncology;2024-09-02
3. Infusion and delivery strategies to maximize the efficacy of CAR-T cell immunotherapy for cancers;Experimental Hematology & Oncology;2024-07-26
4. Application of CAR-T cell therapy targeting mesothelin in solid tumor treatment;Discover Oncology;2024-07-18
5. Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer;Journal of Translational Medicine;2024-04-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3